1. Nuclear ING3 Expression Is Correlated With a Good Prognosis of Breast Cancer
   Xiaoyan Wu et al, 2021, Frontiers in Oncology CrossRef
2. Decreased Nuclear Immunoexpression of ING3 is a Frequent Event in Lip Carcinogenesis
   Joyce Magalhães de Barros et al, 2024, Head and Neck Pathology CrossRef
3. The Biological and Clinical Relevance of Inhibitor of Growth (ING) Genes in Non-Small Cell Lung Cancer
   Elisabeth Smolle et al, 2019, Cancers CrossRef
4. Scientific Research Directions on the Histopathology and Immunohistochemistry of the Cutaneous Squamous Cell Carcinoma: A Scientometric Study
   Iuliu Gabriel Cocuz et al, 2022, Medicina CrossRef
5. Expression and prognostic value of ING3 in advanced laryngeal squamous cell carcinoma
   Neslişah BARLAK et al, 2023, The European Research Journal CrossRef
6. The ubiquitin E3 ligase MDM2 induces chemoresistance in colorectal cancer by degradation of ING3
   Liangliang Zhang et al, 2023, Carcinogenesis CrossRef
7. Molecular mechanisms of inhibitor of growth (ING) family members in health and malignancy
   Mohammad Taheri et al, 2022, Cancer Cell International CrossRef
8. ING3 inhibits the malignant progression of lung adenocarcinoma by negatively regulating ITGB4 expression to inactivate Src/FAK signaling
   Shiliang Cheng et al, 2024, Cellular Signalling CrossRef
9. In silico analysis prediction of HepTH1-5 as a potential therapeutic agent by targeting tumour suppressor protein networks
   Wan-Atirah Azemin et al, 2023, Journal of Biomolecular Structure and Dynamics CrossRef
10. ING3 and ING4 immunoexpression and their relation to the development of benign odontogenic lesions
    Yailit del Carmen Martinez-Vargas et al, 2021, Brazilian Dental Journal CrossRef
11. Prognostic significance of ING3 expression in patients with cancer: A systematic review and meta-analysis
    Zehan Li et al, 2023, Frontiers in Oncology CrossRef